_id
6919e2e03c536f8df2317fe6
Ticker
0RQE.LSE
Name
Idorsia Ltd.
Exchange
LSE
Address
Hegenheimermattweg 91, Allschwil, Switzerland, 4123
Country
UK
Sector
Industry
Currency
GBP
Website
https://www.idorsia.com
Description
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of insomnia. The company's product pipeline includes Lucerastat, a glucosylceramide synthase inhibitor, which is in phase 3 clinical trial to treat fabry disease; Daridorexant, a dual orexin receptor antagonist, which is in phase 2 clinical trial for the treatment of pediatric insomnia; IDOR-1117-2520, a CCR6 receptor antagonist which is in phase 1 clinical program to treat immune-mediated disorders; ACT-777991, a CXCR3 antagonist, which is in preclinical trial to treat vitiligo; and ACT-1004-1239, an ACKR3 receptor antagonist which is preclinical trial for the treatment of progressive multiple sclerosis. It also develops ACT-1016-0707, a LPA 1 receptor antagonist to treat immune-mediated and fibrosis related disorders; IDOR-1141-8472, an orexin 2 receptor agonist to treat orexin-related CNS disorders; and IDOR-1126-6421 to treat organ injury. The company holds a license agreement with Neuro to develop and commercialize clazosentan; collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and optional license and/or research and development collaboration agreement with Neurocrine Biosciences, Inc, to to develop and commercialize ACT-709478, and/or to collaborate in a research program to discover, identify and develop novel calcium channel blocker compounds for follow-on compounds to ACT-709478. Idorsia Ltd was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
Last Close
11.49834726765
Volume
83363
Current Price
4.2637
Change
-6.884887360092709
Last Updated
2025-12-05T15:14:27.060Z
Image
https://logo.clearbit.com/www.idorsia.com
Ipo Date
-
Market Cap
1498178560
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
72241000
Cost Of Revenue
3388000
Gross Profit
68853000
Operating Expenses
71397000
Operating Income
-2544000
Interest Expense
7221444
Pretax Income
-7674000
Net Income
-11375000
Eps
-0.05581452404317959
Dividends Per Share
-
Shares Outstanding
131050000
Income Tax Expense
3700000
EBITDA
6006000
Operating Margin
-3.5215459365180437
Total Other Income Expense Net
-5130000
Cash
70966000
Short Term Investments
11193000
Receivables
69302000
Inventories
66607000
Total Current Assets
249045000
Property Plant Equipment
205000000
Total Assets
498011000
Payables
24720000
Short Term Debt
211438000
Long Term Debt
-
Total Liabilities
1639574000
Equity
-1141563000
Depreciation
4937000
Change In Working Capital
-34462000
Cash From Operations
-35262000
Capital Expenditures
9733000
Cash From Investing
-9733000
Cash From Financing
67039000
Net Change In Cash
21388000
PE
-
PB
-0.7611862507807279
ROE
0.9964408447015188
ROA
-2.284086094483857
FCF
-44995000
Fcf Percent
-0.6228457524120652
Piotroski FScore
0
Health Score
15
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
72241000
Quarters > 0 > income Statement > cost Of Revenue
3388000
Quarters > 0 > income Statement > gross Profit
68853000
Quarters > 0 > income Statement > operating Expenses
71397000
Quarters > 0 > income Statement > operating Income
-2544000
Quarters > 0 > income Statement > interest Expense
7221444
Quarters > 0 > income Statement > pretax Income
-7674000
Quarters > 0 > income Statement > net Income
-11375000
Quarters > 0 > income Statement > eps
-0.05581452404317959
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
203800000
Quarters > 0 > income Statement > income Tax Expense
3700000
Quarters > 0 > income Statement > EBITDA
6006000
Quarters > 0 > income Statement > operating Margin
-3.5215459365180437
Quarters > 0 > income Statement > total Other Income Expense Net
-5130000
Quarters > 0 > balance Sheet > cash
70966000
Quarters > 0 > balance Sheet > short Term Investments
11193000
Quarters > 0 > balance Sheet > receivables
69302000
Quarters > 0 > balance Sheet > inventories
66607000
Quarters > 0 > balance Sheet > total Current Assets
249045000
Quarters > 0 > balance Sheet > property Plant Equipment
205000000
Quarters > 0 > balance Sheet > total Assets
498011000
Quarters > 0 > balance Sheet > payables
24720000
Quarters > 0 > balance Sheet > short Term Debt
211438000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1639574000
Quarters > 0 > balance Sheet > equity
-1141563000
Quarters > 0 > cash Flow > net Income
-11375000
Quarters > 0 > cash Flow > depreciation
4937000
Quarters > 0 > cash Flow > change In Working Capital
-34462000
Quarters > 0 > cash Flow > cash From Operations
-35262000
Quarters > 0 > cash Flow > capital Expenditures
9733000
Quarters > 0 > cash Flow > cash From Investing
-9733000
Quarters > 0 > cash Flow > cash From Financing
67039000
Quarters > 0 > cash Flow > net Change In Cash
21388000
Quarters > 0 > ratios > PE
-0.05581452404317959
Quarters > 0 > ratios > PB
-0.7611862507807279
Quarters > 0 > ratios > ROE
0.9964408447015188
Quarters > 0 > ratios > ROA
-2.284086094483857
Quarters > 0 > ratios > FCF
-44995000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.6228457524120652
Quarters > 0 > health Score
15
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
58883000
Quarters > 1 > income Statement > cost Of Revenue
2441000
Quarters > 1 > income Statement > gross Profit
56442000
Quarters > 1 > income Statement > operating Expenses
-10223000
Quarters > 1 > income Statement > operating Income
66665000
Quarters > 1 > income Statement > interest Expense
7541000
Quarters > 1 > income Statement > pretax Income
63510000
Quarters > 1 > income Statement > net Income
63118000
Quarters > 1 > income Statement > eps
0.3459526597235992
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
182446928
Quarters > 1 > income Statement > income Tax Expense
393000
Quarters > 1 > income Statement > EBITDA
75378000
Quarters > 1 > income Statement > operating Margin
113.21603858499057
Quarters > 1 > income Statement > total Other Income Expense Net
-3155000
Quarters > 1 > balance Sheet > cash
50678000
Quarters > 1 > balance Sheet > short Term Investments
14169000
Quarters > 1 > balance Sheet > receivables
33923000
Quarters > 1 > balance Sheet > inventories
62468000
Quarters > 1 > balance Sheet > total Current Assets
186429000
Quarters > 1 > balance Sheet > property Plant Equipment
211117000
Quarters > 1 > balance Sheet > total Assets
456170000
Quarters > 1 > balance Sheet > payables
25006000
Quarters > 1 > balance Sheet > short Term Debt
208307000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1588352000
Quarters > 1 > balance Sheet > equity
-1132182000
Quarters > 1 > cash Flow > net Income
63118000
Quarters > 1 > cash Flow > depreciation
4327000
Quarters > 1 > cash Flow > change In Working Capital
-35552000
Quarters > 1 > cash Flow > cash From Operations
-60674000
Quarters > 1 > cash Flow > capital Expenditures
182000
Quarters > 1 > cash Flow > cash From Investing
6855000
Quarters > 1 > cash Flow > cash From Financing
-1652000
Quarters > 1 > cash Flow > net Change In Cash
-55698000
Quarters > 1 > ratios > PE
0.3459526597235992
Quarters > 1 > ratios > PB
-0.6870794332656763
Quarters > 1 > ratios > ROE
-5.574898735362336
Quarters > 1 > ratios > ROA
13.83650831926694
Quarters > 1 > ratios > FCF
-60856000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.0335071242973355
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
59900000
Quarters > 2 > income Statement > cost Of Revenue
52605000
Quarters > 2 > income Statement > gross Profit
7295000
Quarters > 2 > income Statement > operating Expenses
85550000
Quarters > 2 > income Statement > operating Income
-78255000
Quarters > 2 > income Statement > interest Expense
5461000
Quarters > 2 > income Statement > pretax Income
-84141000
Quarters > 2 > income Statement > net Income
-84005000
Quarters > 2 > income Statement > eps
-0.44612320764737123
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
188300000
Quarters > 2 > income Statement > income Tax Expense
-136000
Quarters > 2 > income Statement > EBITDA
-54846000
Quarters > 2 > income Statement > operating Margin
-130.64273789649417
Quarters > 2 > income Statement > total Other Income Expense Net
-5886000
Quarters > 2 > balance Sheet > cash
106376000
Quarters > 2 > balance Sheet > short Term Investments
17982000
Quarters > 2 > balance Sheet > receivables
26360000
Quarters > 2 > balance Sheet > inventories
62648000
Quarters > 2 > balance Sheet > total Current Assets
255479000
Quarters > 2 > balance Sheet > property Plant Equipment
216921000
Quarters > 2 > balance Sheet > total Assets
505895000
Quarters > 2 > balance Sheet > payables
35181000
Quarters > 2 > balance Sheet > short Term Debt
208586000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1718040000
Quarters > 2 > balance Sheet > equity
-1212145000
Quarters > 2 > cash Flow > net Income
-84005000
Quarters > 2 > cash Flow > depreciation
4440000
Quarters > 2 > cash Flow > change In Working Capital
56290114
Quarters > 2 > cash Flow > cash From Operations
-11002000
Quarters > 2 > cash Flow > capital Expenditures
740000
Quarters > 2 > cash Flow > cash From Investing
-736000
Quarters > 2 > cash Flow > cash From Financing
26188000
Quarters > 2 > cash Flow > net Change In Cash
14741000
Quarters > 2 > ratios > PE
-0.44612320764737123
Quarters > 2 > ratios > PB
-0.6623421372855558
Quarters > 2 > ratios > ROE
6.930276493323818
Quarters > 2 > ratios > ROA
-16.605224404273613
Quarters > 2 > ratios > FCF
-11742000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.19602671118530884
Quarters > 2 > health Score
21
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
26202000
Quarters > 3 > income Statement > cost Of Revenue
51737000
Quarters > 3 > income Statement > gross Profit
-25535000
Quarters > 3 > income Statement > operating Expenses
64092000
Quarters > 3 > income Statement > operating Income
-89627000
Quarters > 3 > income Statement > interest Expense
5068000
Quarters > 3 > income Statement > pretax Income
-100865000
Quarters > 3 > income Statement > net Income
-101000000
Quarters > 3 > income Statement > eps
-0.5537767928178242
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
182383952
Quarters > 3 > income Statement > income Tax Expense
173000
Quarters > 3 > income Statement > EBITDA
-78143668
Quarters > 3 > income Statement > operating Margin
-342.0616746813221
Quarters > 3 > income Statement > total Other Income Expense Net
-11238000
Quarters > 3 > balance Sheet > cash
91635000
Quarters > 3 > balance Sheet > short Term Investments
11515000
Quarters > 3 > balance Sheet > receivables
23093024
Quarters > 3 > balance Sheet > inventories
67198880
Quarters > 3 > balance Sheet > total Current Assets
198893062
Quarters > 3 > balance Sheet > property Plant Equipment
242579000
Quarters > 3 > balance Sheet > total Assets
512835000
Quarters > 3 > balance Sheet > payables
13315665
Quarters > 3 > balance Sheet > short Term Debt
208661000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1638945000
Quarters > 3 > balance Sheet > equity
-1126110000
Quarters > 3 > cash Flow > net Income
-101038000
Quarters > 3 > cash Flow > depreciation
4859935
Quarters > 3 > cash Flow > change In Working Capital
-67570000
Quarters > 3 > cash Flow > cash From Operations
-143714000
Quarters > 3 > cash Flow > capital Expenditures
466000
Quarters > 3 > cash Flow > cash From Investing
-1230000
Quarters > 3 > cash Flow > cash From Financing
9586
Quarters > 3 > cash Flow > net Change In Cash
-145557000
Quarters > 3 > ratios > PE
-0.5537767928178242
Quarters > 3 > ratios > PB
-0.6905457336693573
Quarters > 3 > ratios > ROE
8.96892843505519
Quarters > 3 > ratios > ROA
-19.6944436319674
Quarters > 3 > ratios > FCF
-144180000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-5.502633386764369
Quarters > 3 > health Score
21
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
112508000
Annuals > 0 > income Statement > cost Of Revenue
179592000
Annuals > 0 > income Statement > gross Profit
-67084000
Annuals > 0 > income Statement > operating Expenses
164930000
Annuals > 0 > income Statement > operating Income
-232014000
Annuals > 0 > income Statement > interest Expense
20124000
Annuals > 0 > income Statement > pretax Income
-263323000
Annuals > 0 > income Statement > net Income
-263757000
Annuals > 0 > income Statement > eps
-1.4456642426996633
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
182446928
Annuals > 0 > income Statement > income Tax Expense
434000
Annuals > 0 > income Statement > EBITDA
-319488000
Annuals > 0 > income Statement > operating Margin
-206.22000213318165
Annuals > 0 > income Statement > total Other Income Expense Net
-31309000
Annuals > 0 > balance Sheet > cash
106376000
Annuals > 0 > balance Sheet > short Term Investments
17982000
Annuals > 0 > balance Sheet > receivables
26360000
Annuals > 0 > balance Sheet > inventories
62648000
Annuals > 0 > balance Sheet > total Current Assets
255479000
Annuals > 0 > balance Sheet > property Plant Equipment
216921000
Annuals > 0 > balance Sheet > total Assets
505895000
Annuals > 0 > balance Sheet > payables
35181000
Annuals > 0 > balance Sheet > short Term Debt
208586000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1718040000
Annuals > 0 > balance Sheet > equity
-1212145000
Annuals > 0 > cash Flow > net Income
-263757000
Annuals > 0 > cash Flow > depreciation
19000000
Annuals > 0 > cash Flow > change In Working Capital
-42663000
Annuals > 0 > cash Flow > cash From Operations
-370232000
Annuals > 0 > cash Flow > capital Expenditures
2998000
Annuals > 0 > cash Flow > cash From Investing
305057000
Annuals > 0 > cash Flow > cash From Financing
26108000
Annuals > 0 > cash Flow > net Change In Cash
-38676000
Annuals > 0 > ratios > PE
-1.4456642426996633
Annuals > 0 > ratios > PB
-0.5254204210407171
Annuals > 0 > ratios > ROE
21.759525469312667
Annuals > 0 > ratios > ROA
-52.13670821020172
Annuals > 0 > ratios > FCF
-373230000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-3.317364098552992
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
152386000
Annuals > 1 > income Statement > cost Of Revenue
7150000
Annuals > 1 > income Statement > gross Profit
145236000
Annuals > 1 > income Statement > operating Expenses
400381000
Annuals > 1 > income Statement > operating Income
-255145000
Annuals > 1 > income Statement > interest Expense
20668000
Annuals > 1 > income Statement > pretax Income
-294253000
Annuals > 1 > income Statement > net Income
-297921000
Annuals > 1 > income Statement > eps
-1.671394188962507
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
178247000
Annuals > 1 > income Statement > income Tax Expense
3668000
Annuals > 1 > income Statement > EBITDA
-254551000
Annuals > 1 > income Statement > operating Margin
-167.43336001994933
Annuals > 1 > income Statement > total Other Income Expense Net
-39108000
Annuals > 1 > balance Sheet > cash
145052000
Annuals > 1 > balance Sheet > short Term Investments
12764000
Annuals > 1 > balance Sheet > receivables
20339000
Annuals > 1 > balance Sheet > inventories
59146000
Annuals > 1 > balance Sheet > total Current Assets
276284000
Annuals > 1 > balance Sheet > property Plant Equipment
209736000
Annuals > 1 > balance Sheet > total Assets
499996000
Annuals > 1 > balance Sheet > payables
19910000
Annuals > 1 > balance Sheet > short Term Debt
206122000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1468714000
Annuals > 1 > balance Sheet > equity
-968718000
Annuals > 1 > cash Flow > net Income
-297921000
Annuals > 1 > cash Flow > depreciation
19034000
Annuals > 1 > cash Flow > change In Working Capital
-75069000
Annuals > 1 > cash Flow > cash From Operations
-629296000
Annuals > 1 > cash Flow > capital Expenditures
9398000
Annuals > 1 > cash Flow > cash From Investing
632614000
Annuals > 1 > cash Flow > cash From Financing
-197000
Annuals > 1 > cash Flow > net Change In Cash
-946000
Annuals > 1 > ratios > PE
-1.671394188962507
Annuals > 1 > ratios > PB
-0.6423176069815985
Annuals > 1 > ratios > ROE
30.754151362935346
Annuals > 1 > ratios > ROA
-59.58467667741342
Annuals > 1 > ratios > FCF
-638694000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-4.191290538500912
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
97102000
Annuals > 2 > income Statement > cost Of Revenue
6266000
Annuals > 2 > income Statement > gross Profit
90836000
Annuals > 2 > income Statement > operating Expenses
893800000
Annuals > 2 > income Statement > operating Income
-802964000
Annuals > 2 > income Statement > interest Expense
17172000
Annuals > 2 > income Statement > pretax Income
-820089000
Annuals > 2 > income Statement > net Income
-827896000
Annuals > 2 > income Statement > eps
-4.665937757137866
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
177434000
Annuals > 2 > income Statement > income Tax Expense
7807000
Annuals > 2 > income Statement > EBITDA
-783088000
Annuals > 2 > income Statement > operating Margin
-826.9283845852815
Annuals > 2 > income Statement > total Other Income Expense Net
-17124000
Annuals > 2 > balance Sheet > cash
145998000
Annuals > 2 > balance Sheet > short Term Investments
330326000
Annuals > 2 > balance Sheet > receivables
49348000
Annuals > 2 > balance Sheet > inventories
35840000
Annuals > 2 > balance Sheet > total Current Assets
596438000
Annuals > 2 > balance Sheet > property Plant Equipment
245468000
Annuals > 2 > balance Sheet > total Assets
904180000
Annuals > 2 > balance Sheet > payables
25435000
Annuals > 2 > balance Sheet > short Term Debt
8921000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1565138000
Annuals > 2 > balance Sheet > equity
-660958000
Annuals > 2 > cash Flow > net Income
-827896000
Annuals > 2 > cash Flow > depreciation
19829000
Annuals > 2 > cash Flow > change In Working Capital
-64697000
Annuals > 2 > cash Flow > cash From Operations
-859108000
Annuals > 2 > cash Flow > capital Expenditures
27058000
Annuals > 2 > cash Flow > cash From Investing
743901000
Annuals > 2 > cash Flow > cash From Financing
162310000
Annuals > 2 > cash Flow > net Change In Cash
44646000
Annuals > 2 > ratios > PE
-4.665937757137866
Annuals > 2 > ratios > PB
-0.9371043352225104
Annuals > 2 > ratios > ROE
125.25697548104418
Annuals > 2 > ratios > ROA
-91.56318432170586
Annuals > 2 > ratios > FCF
-886166000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-9.126135404008156
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
35349000
Annuals > 3 > income Statement > cost Of Revenue
18033000
Annuals > 3 > income Statement > gross Profit
17316000
Annuals > 3 > income Statement > operating Expenses
648353000
Annuals > 3 > income Statement > operating Income
-613004000
Annuals > 3 > income Statement > interest Expense
27937000
Annuals > 3 > income Statement > pretax Income
-634805000
Annuals > 3 > income Statement > net Income
-634595000
Annuals > 3 > income Statement > eps
-3.766186062879494
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
168498048
Annuals > 3 > income Statement > income Tax Expense
-210000
Annuals > 3 > income Statement > EBITDA
-588835000
Annuals > 3 > income Statement > operating Margin
-1734.1480664233782
Annuals > 3 > income Statement > total Other Income Expense Net
-21801000
Annuals > 3 > balance Sheet > cash
101352000
Annuals > 3 > balance Sheet > short Term Investments
936773000
Annuals > 3 > balance Sheet > receivables
16697000
Annuals > 3 > balance Sheet > inventories
21717000
Annuals > 3 > balance Sheet > total Current Assets
1077462000
Annuals > 3 > balance Sheet > property Plant Equipment
223436000
Annuals > 3 > balance Sheet > total Assets
1482958000
Annuals > 3 > balance Sheet > payables
26860000
Annuals > 3 > balance Sheet > short Term Debt
10312000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1378754000
Annuals > 3 > balance Sheet > equity
104204000
Annuals > 3 > cash Flow > net Income
-634595000
Annuals > 3 > cash Flow > depreciation
18033000
Annuals > 3 > cash Flow > change In Working Capital
-841000
Annuals > 3 > cash Flow > cash From Operations
-589895000
Annuals > 3 > cash Flow > capital Expenditures
30931000
Annuals > 3 > cash Flow > cash From Investing
-53257000
Annuals > 3 > cash Flow > cash From Financing
604146000
Annuals > 3 > cash Flow > net Change In Cash
-39458000
Annuals > 3 > ratios > PE
-3.766186062879494
Annuals > 3 > ratios > PB
5.644629629941269
Annuals > 3 > ratios > ROE
-608.9929369314037
Annuals > 3 > ratios > ROA
-42.792513341578115
Annuals > 3 > ratios > FCF
-620826000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-17.562759908342528
Annuals > 3 > health Score
11
Valuation > metrics > PE
-0.05581452404317959
Valuation > metrics > PB
-0.7611862507807279
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
0.9964408447015188
Profitability > metrics > ROA
-4.567447650023088
Profitability > metrics > Net Margin
-0.1574590606442325
Profitability > final Score
2
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.35228411381435626
Risk > final Score
29
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.0545693984535778
Liquidity > metrics > Quick Ratio
0.7725251738243041
Liquidity > final Score
65
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
60
Prev Profitabilities > 1
14
Prev Profitabilities > 2
18
Prev Risks > 0
65
Prev Risks > 1
-27
Prev Risks > 2
-41
Prev Liquidities > 0
37
Prev Liquidities > 1
66
Prev Liquidities > 2
40
Updated At
2026-01-20T22:59:11.964Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.2
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-30
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.4009
Earnings History > 1 > eps Estimate
-0.25
Earnings History > 1 > eps Difference
-0.1509
Earnings History > 1 > surprise Percent
-60.36
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-30
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0461
Earnings History > 2 > eps Estimate
-0.23
Earnings History > 2 > eps Difference
0.1839
Earnings History > 2 > surprise Percent
79.9565
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-19
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.2331
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-05
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.4432
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-29
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.4624
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-07-25
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.5459
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-21
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.128
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-20
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.6533
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.9637
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-1.0275
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-1.1921
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2022-12-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-1.0863
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-12-02
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.06
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-07-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.08
Earnings History > 14 > eps Estimate
-11.3
Earnings History > 14 > eps Difference
11.22
Earnings History > 14 > surprise Percent
99.292
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-1.1152
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2021-12-31
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-1.4554
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-30
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.09
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-08
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.09
Earnings History > 18 > eps Estimate
-12.7
Earnings History > 18 > eps Difference
12.61
Earnings History > 18 > surprise Percent
99.2913
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.6274
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-03
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.8518
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-24
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.22
Earnings History > 21 > eps Estimate
-15.85
Earnings History > 21 > eps Difference
15.63
Earnings History > 21 > surprise Percent
98.612
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-20
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.24
Earnings History > 22 > eps Estimate
-27.85
Earnings History > 22 > eps Difference
27.61
Earnings History > 22 > surprise Percent
99.1382
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.9024
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-26
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-1.0658
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-12-06
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.12
Earnings History > 25 > eps Estimate
-16.8
Earnings History > 25 > eps Difference
16.68
Earnings History > 25 > surprise Percent
99.2857
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-07-11
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.45
Earnings History > 26 > eps Estimate
-37.56
Earnings History > 26 > eps Difference
37.11
Earnings History > 26 > surprise Percent
98.8019
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-0.801
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-27
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.8146
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-12-14
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-0.17
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-0.6662
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-06-27
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.25
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2017-12-31
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
0.5618
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-12-14
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
-
Earnings History > 33 > eps Actual
-0.3
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-06-29
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
-
Earnings History > 34 > eps Actual
-0.25
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.25
Earnings History > 34 > surprise Percent
-
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of insomnia. The company's product pipeline includes Lucerastat, a glucosylceramide synthase inhibitor, which is in phase 3 clinical trial to treat fabry disease; Daridorexant, a dual orexin receptor antagonist, which is in phase 2 clinical trial for the treatment of pediatric insomnia; IDOR-1117-2520, a CCR6 receptor antagonist which is in phase 1 clinical program to treat immune-mediated disorders; ACT-777991, a CXCR3 antagonist, which is in preclinical trial to treat vitiligo; and ACT-1004-1239, an ACKR3 receptor antagonist which is preclinical trial for the treatment of progressive multiple sclerosis. It also develops ACT-1016-0707, a LPA 1 receptor antagonist to treat immune-mediated and fibrosis related disorders; IDOR-1141-8472, an orexin 2 receptor agonist to treat orexin-related CNS disorders; and IDOR-1126-6421 to treat organ injury. The company holds a license agreement with Neuro to develop and commercialize clazosentan; collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and optional license and/or research and development collaboration agreement with Neurocrine Biosciences, Inc, to to develop and commercialize ACT-709478, and/or to collaborate in a research program to discover, identify and develop novel calcium channel blocker compounds for follow-on compounds to ACT-709478. Idorsia Ltd was incorporated in 2017 and is headquartered in Allschwil, Switzerland.
Stock Price
£0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Idorsia Ltd.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.2
Date
2025-09-30
EPS Actual
-0.4009
EPS Estimate
-0.25
EPS Difference
-0.1509
Surprise Percent
-60.36%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.